moxifloxacin has been researched along with Cerebral Nocardiosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bouza, E; Cercenado, E; Cuevas, O; Marín, M; Martínez-Alarcón, J; Sánchez-Martínez, M | 1 |
| Daw-Garza, A; Lozano-Garza, HG; Ocampo-Candiani, J; Rocha, NC; Said-Fernández, S; Vera-Cabrera, L; Waksman de Torres, N; Welsh, O | 1 |
| Durrani, A; Jhanji, V; Kowalski, RP; Verner, A | 1 |
| Mansoori, T; Reddy, AK; Sistla, A; Srirampur, A; Suresh, N | 1 |
| Chandrika, TN; Katta, KR; Mansoori, T; Reddy, AK; Srirampur, A | 1 |
| Acharya, NR; Glidden, DV; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; O'Brien, KS; Oldenburg, CE; Porco, TC; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Whitcher, JP; Zegans, ME | 1 |
| Fujita, T; Kitamura, A; Miki, Y; Nakamura, H; Nakamura, T; Sakurai, T; Tomita, K; Toyoda, F | 1 |
| Acharya, NR; Lalitha, P; Lietman, TM; Mascarenhas, J; McLeod, SD; Oldenburg, CE; Priya, JL; Rajaraman, R; Ravindran, M; Ray, KJ; Srinivasan, M; Sy, A; Zegans, ME | 1 |
| Fernandes, M; Mittal, V | 1 |
| Acharya, NR; Geetha, M; Glidden, D; Karpagam, R; Lietman, TM; McLeod, SD; Oldenburg, CE; Prajna, L; Ray, KJ; Srinivasan, M; Sun, CQ | 1 |
| Berçot, B; Fihman, V; Loirat, P; Losser, MR; Mateo, J; Pors, MJ; Raskine, L; Riahi, J | 1 |
| Gonzalez-Fernandez, F; Patel, NR; Reidy, JJ | 1 |
| Dahan, K; Delahousse, M; El Kabbaj, D; Pastural, M; Venditto, M | 1 |
| Fellows, GA; Kalsi, PS; Martin, AJ | 1 |
| Cooke, RP; Eldridge, PR; Iqbal, HJ; Kandasamy, J | 1 |
2 review(s) available for moxifloxacin and Cerebral Nocardiosis
| Article | Year |
|---|---|
A Case of Nocardia farcinica Keratitis in a Pediatric Contact Lens Wearer.
Topics: Adolescent; Anti-Bacterial Agents; Contact Lenses, Hydrophilic; Corneal Ulcer; DNA, Bacterial; Eye Infections, Bacterial; Humans; Male; Microbial Sensitivity Tests; Moxifloxacin; Nocardia; Nocardia Infections; RNA, Ribosomal, 16S; Visual Acuity | 2020 |
Nocardia keratitis after laser in situ keratomileusis: clinicopathologic correlation.
Topics: Administration, Topical; Anti-Bacterial Agents; Aza Compounds; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Imipenem; Keratitis; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Middle Aged; Moxifloxacin; Necrosis; Nocardia asteroides; Nocardia Infections; Quinolines; Recurrence | 2005 |
3 trial(s) available for moxifloxacin and Cerebral Nocardiosis
| Article | Year |
|---|---|
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Ophthalmic Solutions; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2014 |
Nocardia keratitis: clinical course and effect of corticosteroids.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Double-Blind Method; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Polymerase Chain Reaction; Prednisolone; Quinolines; Treatment Outcome; Visual Acuity | 2012 |
Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Bacteria; Corneal Ulcer; Double-Blind Method; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Glucocorticoids; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Pneumococcal Infections; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Streptococcus pneumoniae | 2013 |
10 other study(ies) available for moxifloxacin and Cerebral Nocardiosis
| Article | Year |
|---|---|
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Minocycline; Nocardia; Nocardia Infections; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline | 2007 |
In vivo therapeutic effect of gatifloxacin on BALB/c mice infected with Nocardia brasiliensis.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Mice; Mice, Inbred BALB C; Nocardia; Nocardia Infections; Oxazolidinones; Treatment Outcome | 2008 |
Retrocorneal abscess: an unusual presentation of Nocardia keratitis after Descemet's stripping endothelial keratoplasty.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Antihypertensive Agents; Atropine; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Bacterial; Female; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Mydriatics; Nocardia; Nocardia Infections; Postoperative Complications; Slit Lamp Microscopy; Tomography, Optical Coherence; Visual Acuity | 2020 |
Management of Nocardia Interface Keratitis After Descemet Membrane Endothelial Keratoplasty.
Topics: Administration, Ophthalmic; Aged; Anti-Bacterial Agents; Atropine; Ciprofloxacin; Combined Modality Therapy; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratitis; Male; Moxifloxacin; Nocardia asteroides; Nocardia Infections; Ophthalmic Solutions; Reoperation; Retrospective Studies; Visual Acuity | 2019 |
[A case of primary pulmonary nocardiosis with multiple pulmonary nodules successfully treated with moxifloxacin].
Topics: Adolescent; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Humans; Lung Diseases; Male; Moxifloxacin; Nocardia Infections; Quinolines | 2009 |
Cotrimoxazole-resistant Nocardia sclerokeratitis: effective therapy with fourth-generation fluoroquinolones.
Topics: Administration, Oral; Administration, Topical; Aged; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; Scleritis; Trimethoprim, Sulfamethoxazole Drug Combination | 2012 |
First successful treatment of Nocardia farcinica brain abscess with moxifloxacin.
Topics: Anti-Infective Agents; Aza Compounds; Biopsy, Needle; Brain Abscess; Fluoroquinolones; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Lung Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; RNA, Ribosomal, 16S; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Intracranial Nocardia recurrence during fluorinated quinolones therapy.
Topics: Amikacin; Aza Compounds; Brain Abscess; Drug Combinations; Fluoroquinolones; Humans; Imipenem; Kidney Transplantation; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; Sulfamethizole; Trimethoprim | 2006 |
Nocardia farcinica brain abscess in a patient without immunocompromise.
Topics: Anti-Infective Agents; Aza Compounds; Brain Abscess; Fluoroquinolones; Humans; Immunocompetence; Male; Middle Aged; Moxifloxacin; Nocardia; Nocardia Infections; Quinolines; Radiography | 2007 |
Primary Nocardia farcinica brain abscess with secondary meningitis and ventriculitis in an immunocompetent patient, successfully treated with moxifloxacin.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Brain Abscess; Cerebral Ventricles; Drainage; Encephalitis; Fluoroquinolones; Humans; Immunocompetence; Male; Meningitis, Bacterial; Moxifloxacin; Neurosurgical Procedures; Nocardia Infections; Occipital Lobe; Postoperative Care; Quinolines; Skull Base | 2008 |